Shionogi Overview
- Year Founded
-
1878
- Status
-
Public
- Employees
-
6,773
- Stock Symbol
-
4507
- Investments
-
51
- Share Price
-
$19.84
- (As of Friday Closing)
Shionogi General Information
Description
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. The company engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late-stage drug discovery through commercial production. It provides products and services in Japan, Europe, North America, and other regions.
Contact Information
Website
www.shionogi.comCorporate Office
- Grand Green Osaka, Park Tower 26 Floor
- 5-54 Ofukacho, Kita-ku
- Osaka, 530-0011
- Japan
Corporate Office
- Grand Green Osaka, Park Tower 26 Floor
- 5-54 Ofukacho, Kita-ku
- Osaka, 530-0011
- Japan
Shionogi Stock Performance
As of 13-Nov-2026, Shionogi’s stock price is $19.84. Its current market cap is $16.9B with 851M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $19.84 | $19.64 | $16.52 - $23.77 | $16.9B | 851M | 2.91M | $1.80 |
Shionogi Financials Summary
As of 30-Sep-2026, Shionogi has a trailing 12-month revenue of $4.05B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 15,965,364 | 14,901,579 | 9,082,528 | 11,359,904 |
| Revenue | 4,047,996 | 3,315,159 | 2,873,924 | 3,011,153 |
| EBITDA | 1,693,408 | 1,285,076 | 1,164,185 | 1,187,855 |
| Net Income | 1,535,774 | 1,361,149 | 1,117,620 | 1,121,394 |
| Total Assets | 16,777,633 | 16,119,744 | 10,260,123 | 9,361,863 |
| Total Debt | 4,338,752 | 4,281,262 | 146,229 | 76,776 |
Shionogi Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Shionogi Comparisons
Industry
Financing
Details
Shionogi Competitors (47)
One of Shionogi’s 47 competitors is Chugai Pharmaceutical, a Corporate Backed or Acquired company based in Tokyo, Japan.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Chugai Pharmaceutical | Corporate Backed or Acquired | Tokyo, Japan | ||||
| Rigel Pharmaceuticals | Formerly VC-backed | South San Francisco, CA | ||||
| Astellas Pharma | Corporation | Tokyo, Japan | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Cipla | Corporation | Mumbai, India |
Shionogi Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Shionogi Patents
Shionogi Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026179068-A | Method for producing tetrahydrobenzophrodiazepinone compounds and their synthetic intermediates | Pending | 28-Apr-2025 | ||
| WO-2026230499-A1 | Standard reagent for measurement of bnp, nt-probnp, or probnp | Pending | 28-Apr-2025 | ||
| JP-2026178195-A | Topical pharmaceutical composition containing a nitrogen-containing spiroring compound or a salt thereof | Pending | 25-Apr-2025 | ||
| WO-2026211942-A1 | Analysis system, analysis method, control program, and recording medium | Pending | 04-Apr-2025 | ||
| WO-2026211871-A1 | Novel cationic lipid | Pending | 31-Mar-2025 |
Shionogi Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Shionogi Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Shionogi Investments & Acquisitions (51)
Shionogi’s most recent deal was a Merger/Acquisition with IntraBio for . The deal was made on 05-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| IntraBio | 05-Oct-2026 | Merger/Acquisition | Drug Discovery | ||
| Celaid Therapeutics | 04-Oct-2026 | Later Stage VC | Drug Discovery | ||
| Dioseve | 12-Jun-2026 | Later Stage VC | Biotechnology | ||
| Restore Vision | 15-Apr-2026 | Later Stage VC | Drug Discovery | ||
| Shionogi-Apnimed Sleep Science | 06-Apr-2026 | Merger/Acquisition | Drug Discovery |
Shionogi ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
24.17 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Shionogi Exits (5)
Shionogi’s most recent exit was on 03-Oct-2022 from Pixie Dust Technologies. The exit was categorized as with 5 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Pixie Dust Technologies | 03-Oct-2022 | Completed |
|
||
| Nemesis Bioscience | 15-Jun-2018 | Completed |
|
||
| Pioneer (Drug Discovery) | 14-Sep-2015 | Completed |
|
||
| StemRIM | 15-Dec-2014 | Completed |
|
||
| Enanta Pharmaceuticals | 31-Aug-2004 | Later Stage VC | Completed |
|
Shionogi Affiliates
Subsidiaries (8)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Ping An Shionogi | Shanghai, China | 2020 | |
| Ping An-Shionogi | Shanghai, China | 2020 | |
| Shionogi Healthcare | Osaka, Japan | 2016 | |
| Qpex | San Diego, CA | 2015 | |
| UMN Pharma | Tokyo, Japan | 2004 |
Shionogi FAQs
-
When was Shionogi founded?
Shionogi was founded in 1878.
-
Where is Shionogi headquartered?
Shionogi is headquartered in Osaka, Japan.
-
What is the size of Shionogi?
Shionogi has 6,773 total employees.
-
What industry is Shionogi in?
Shionogi’s primary industry is Pharmaceuticals.
-
Is Shionogi a private or public company?
Shionogi is a Public company.
-
What is Shionogi’s stock symbol?
The ticker symbol for Shionogi is 4507.
-
What is the current stock price of Shionogi?
As of 13-Nov-2026 the stock price of Shionogi is $19.84.
-
What is the current market cap of Shionogi?
The current market capitalization of Shionogi is $16.9B.
-
What is Shionogi’s current revenue?
The trailing twelve month revenue for Shionogi is $4.05B.
-
Who are Shionogi’s competitors?
Chugai Pharmaceutical, Rigel Pharmaceuticals, Astellas Pharma, Novartis, and Cipla are some of the 47 competitors of Shionogi.
-
What is Shionogi’s annual earnings per share (EPS)?
Shionogi’s EPS for 12 months was $1.80.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
